当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202014
编号:13478263
整合素α5与上皮性卵巢癌的相关性研究(4)
http://www.100md.com 2020年5月15日 《中国医药导报》 202014
     [16] Xiao Y,Li Y,Tao H,et al. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway [J]. Cancer Lett,2018(433):199-209.

    [17] Zutter MM,Mazoujian G,Santoro SA. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast [J]. Am J Pathol,1990,137(4):863-870.

    [18] Lu L,Xie R,Rong W,et al. Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker [J]. Mol Oncol,2019,13(12):2697-2714.

    [19] 向小芳,楊桂芳,杨倩.整合素α5β1和血管内皮生长因子在结直肠癌中的表达及临床意义[J].中华实验外科杂志,2012,29(2):119-201.

    [20] Pelillo C,Mollica H,Eble JA,et al. Inhibition of adhesion,migration and of alpha5beta1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A [J]. J Inorg Biochem,2016,160:225-235.

    (收稿日期:2019-11-14 本文编辑:封 华), 百拇医药(穆翔 杜维民 史可心 张裕民 张萍)
上一页1 2 3 4